Brain, Vol. 119, No. 3, 815-822, 1996
© 1996 Guarantors of Brain
research-article |
Effects of magnetic stimulation over supplementary motor area on movement in Parkinson's disease
1Geriatric Research Unit, Kingston Centre, Cheltenham Victoria, Australia 2The Australian Neuromuscular research Institute, Queen Elizabeth II Medical Centre Nedlands, Australia 3Department of Psychology, Monash University Clayton Victoria, Australia
Correspondence to:
Correspondence to: Ross Cunnington, Department of Psycology, Monash University, Clayton 3168, Victoria, Australia
Movement execution can be delayed by transcranial magnetic stimulation delivered over primary motor cortical areas, resulting in transient inhibition of cortico-motor output. Inhibition or disruption of higher-order motor planning and preparatory processes, such as are through to occur in the supplementary motor area (SMA), would allow an examination of processes at other stages of the motor control system. In this study, six subjects with Parkinson's disease and six healthy control subjects performed a non-cued sequential finger movement task. At various times relative to movement, high-intensity single-pulse magnetic stimulation was delivered over the region of the SMA, with minimal current spread to primary motor areas. When magnetic stimulation was given at early stages during the movement for parkinsonian subjects, movement times were significantly increased, indicating disrupted movements. Supplementary motor area stimulation had no effect when delivered during later stages of the movement or immediately prior ot movement onset, and had no apparent effect on contorl subjects at any time. It is therefore suggested that the SMA is important in motor planning and preparatory processes, since SMA stimulation has no effect on movements in their later stages when planning may be complete, but may disrupt movements in their early stages, when planning may be complete, but may idsrupt movements in their early stages, when preparation for later stages may still be in progress. Further, possible instability of motor planning/preparation processes in Parkinson's disease is suggested, since these processes appeared more susceptible to disruption by magnetic stimulation in parkinsonian subjects than controls.
magnetic stimulation; supplementary motor area; movement time; Parkinson's disease
Received November 27, 1995. Accepted January 25, 1996.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F Fregni, D K Simon, A Wu, and A Pascual-Leone Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature J. Neurol. Neurosurg. Psychiatry, December 1, 2005; 76(12): 1614 - 1623. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sakreida, R. I. Schubotz, U. Wolfensteller, and D. Y. von Cramon Motion Class Dependency in Observers' Motor Areas Revealed by Functional Magnetic Resonance Imaging J. Neurosci., February 9, 2005; 25(6): 1335 - 1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Murase, J. C. Rothwell, R. Kaji, R. Urushihara, K. Nakamura, N. Murayama, T. Igasaki, M. Sakata-Igasaki, T. Mima, A. Ikeda, et al. Subthreshold low-frequency repetitive transcranial magnetic stimulation over the premotor cortex modulates writer's cramp Brain, January 1, 2005; 128(1): 104 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsunaga, A. Maruyama, T. Fujiwara, R. Nakanishi, S. Tsuji, and J. C. Rothwell Increased corticospinal excitability after 5 Hz rTMS over the human supplementary motor area J. Physiol., January 1, 2005; 562(1): 295 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Escola, Th. Michelet, F. Macia, D. Guehl, B. Bioulac, and P. Burbaud Disruption of information processing in the supplementary motor area of the MPTP-treated monkey: A clue to the pathophysiology of akinesia? Brain, January 1, 2003; 126(1): 95 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Berardelli, J. C. Rothwell, P. D. Thompson, and M. Hallett Pathophysiology of bradykinesia in Parkinson's disease Brain, November 1, 2001; 124(11): 2131 - 2146. [Abstract] [Full Text] [PDF] |
||||



